Filter by
Filter by
Early Toxicity and Patient-Reported Cosmetic Outcomes in Patients Treated With Adjuvant Proton-Based Radiotherapy After Breast-Conserving Surgery.
This study reported early toxicity and cosmetic outcomes of 21 patients treated with breast-conserving surgery and adjuvant PBT. Grade 2 and 3 dermatitis...
CNS & Leptomeningeal Disease
Minesh Mehta covers three indications that are very promising for proton therapy: leptomeningeal disease, low-grade glioma, and glioblastoma. Watch the talk's...
Proton Therapy for Locally Advanced Breast Cancer with a Focus on Cardiac Benefits
Shannon MacDonald covers one of proton therapy's growing indications: breast cancer. In her talk, she focuses on locally advanced breast cancer and cardiac...
DynamicARC: the Future of Proton Therapy
DynamicARC® proton therapy is one of the most promising developments in proton radiation therapy, as it allows dynamic irradiation while the gantry is rotating...
Conventional versus hypofractionated postmastectomy proton radiotherapy in the USA (MC1631): a randomised phase 2 trial.
Published in the Lancet Oncology, this randomized phase 2 study by the Mayo group was set to compare conventional fractionated (50 Gy in 25 fractions of 2 Gy)...
Reconstructive complications and early toxicity in breast cancer patients treated with proton-based postmastectomy radiation therapy.
This study compared acute toxicities and reconstructive complications in patients treated with proton-based (n = 11)and photon-based PMRT (n = 26). Grade 2 skin...
Future Perspectives of Proton Therapy in Minimizing the Toxicity of Breast Cancer Radiotherapy.
A review article compared the clinical evidence including the parameters of the dose distribution in organs at risk, such as the heart, blood vessels, and lungs...